4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000899243-22-006417
See Remarks acquired 32,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zawel Leigh See Remarks | 2022-02-11 | Grant or award | +32,500 | 69,785 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Zawel Leigh See Remarks | 2022-02-11 | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…